© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
The IDH1 inhibitor is the third medication approved this year for hard-to-treat bile duct cancer.
IDH1 inhibitor delayed progression of this often aggressive cancer of the bile ducts.
Tibsovo led to complete remission in some people with acute myeloid leukemia.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
